Background: Leucas aspera (LA) is poorly soluble in water and has a low oral bioavailability, despite its strong antioxidant and hepatoprotective characteristics. Methodology: Phytosomes were prepared by the solvent evaporation method. Phytochemical screening and in vitro antioxidant evaluations were conducted on LA ethanolic leaf extract utilizing DPPH and hydrogen peroxide scavenging tests. The three-level Box-Behnken design was used to determine the drug-to-phospholipid ratio, reaction temperature, and reflux time as independent variables in the optimization of LA-loaded phytosomes (LA-PPS). Results and Discussion: Nano-sized vesicles about 137.76 ± 3.26 nm diameter, a high (i.e., 82.15 ± 0.23 %) entrapment efficiency (EE), a low polydispersity index, and an appropriate zeta potential of approximately -25.36 mV; the F1 formulation showed good stability. The effective complexation and conversion of LA into an amorphous, molecularly distributed state inside the phospholipid matrix was validated by physicochemical characterization using FTIR, DSC, XRD, and SEM. Following non-Fickian diffusion kinetics, the F1 formulation showed substantially enhanced drug solubility in water and prolonged drug release, with an accumulation of almost 82.15 ± 0.23 % over 24 h. Optimized LA-PPS showed better hepatoprotective efficacy than plain LA extract, restored antioxidant enzyme levels, decreased lipid peroxidation, and considerably normalized liver function indicators in an in vivo study using a CCl₄-induced hepatotoxicity rat model. Conclusion: The results indicate that the optimized LA phytosomal formulation (i.,e F1 shows promising results as a nanocarrier for improving the therapeutic effectiveness of Leucas aspera (LA) in hepatic diseases. The method significantly increased the oral bioavailability (BA) of LA, as evidenced by pharmacokinetic evaluation.